期刊
CURRENT OPINION IN PEDIATRICS
卷 13, 期 6, 页码 539-545出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00008480-200112000-00008
关键词
-
类别
资金
- NCI NIH HHS [CA18221, CA15704, CA78902, P01 CA078902] Funding Source: Medline
- NHLBI NIH HHS [HL36444] Funding Source: Medline
Hematopoietic stem cell transplantation (HCT) may offer the only curative therapy for certain life-threatening immune deficiency disorders. Conventional HCT poses a risk to patients for severe morbidity, mortality, and late sequelae resulting from myeloablative preparative regimens. This review summarizes the development of nonmyeloablative regimens that have the potential to reduce both short- and long-term risks of HCT. Results of NM-HCT in a small number of patients indicate that this procedure may play an important role in treating life-threatening immune deficiencies. (C) 2001 Lippincott Williams & Wilkins, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据